IGF2BP2 and breast carcinoma: Furthermore, biological function experiments showed that GAS5 suppressed breast cancer growth via IGF2BP2/QKI, and this inhibitory effect was modulated by FTO both in vitro and in vivo, thus representing a promising strategy for the treatment of breast cancer.